Ann D Rhoads's Net Worth
$1.38 Million
Who is Ann D Rhoads?
Ann D Rhoads has an estimated net worth of $1.38 Million. This is based on reported shares across multiple companies, which include GLOBUS MEDICAL INC, QUIDEL CORP /DE/, iTeos Therapeutics, Inc., ZOGENIX, INC., Repare Therapeutics Inc., NOVELLUS SYSTEMS INC, Evoke Pharma Inc, IRIDEX CORP, Forty Seven, Inc., and QuidelOrtho Corp.
SEC CIK
Ann D Rhoads's CIK is 0001250252
Past Insider Trading and Trends
2022 was Ann D Rhoads's most active year for acquiring shares with 10 total transactions. Ann D Rhoads's most active month to acquire stocks was the month of April. 2020 was Ann D Rhoads's most active year for disposing of shares, totalling 6 transactions. Ann D Rhoads's most active month to dispose stocks was the month of May. 2011 saw Ann D Rhoads paying a total of $200,000.00 for 285,000 shares, this is the most they've acquired in one year. In 2020 Ann D Rhoads cashed out on 363,100 shares for a total of $183,597.70, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GLOBUS MEDICAL INC (GMED) Snapshot price: $69.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +87.40% | 20K |
$47.64 | -$183,500.00 | 42.88K |
Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
| +48.75% | 7.5K |
$12.59 | $94,425.00 | 22.88K |
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
∞
| 15.38K |
$10.66 | $163,993.44 | 15.38K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
QUIDEL CORP /DE/ No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.25K |
—
|
—
|
0
|
May 27
| |||
Form 4
| +260.26% | 1.62K |
—
|
—
| 2.25K |
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
∞
| 624 |
—
|
—
| 624 |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
iTeos Therapeutics, Inc. (ITOS) Snapshot price: $14.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ZOGENIX, INC. No price found
EVP, CFO, Treasurer & Sec.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
| -3.93% | -19.23K |
$2.10 | -$40,314.12 | 469.98K |
Jun 2 - Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
| +30.02% | 46K |
—
|
—
| 199.21K |
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| +13.13% | 17.5K |
$1.19 | $20,825.00 | 150.74K |
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
|
∞
| 100K |
$2.00 | $200,000.00 | 100K |
Sep 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 17K |
$4.00 | $68,000.00 | 17K |
Dec 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Repare Therapeutics Inc. (RPTX) Snapshot price: $2.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
∞
| 4K |
$20.00 | $80,000.00 | 4K |
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |